Pre-operative Carboplatin/Paclitaxel <i>Versus</i> 5-Fluorouracil (5-FU)-based Chemoradiotherapy for Older Adults With Esophageal Cancer.

导出原文传递

翻译打印收藏纠错

作者： Mohammed,Al-Jumayli ^[1] ; Khalil,Choucair ^[2] ; Ammar,Al-Obaidi ^[3] ; Robin,Park ^[4] ; Ajay,Bansal ^[5] ; Joaquina,Baranda ^[6] ; Weijing,Sun ^[1] ; Anwaar,Saeed ^[1]

作者单位： Department of Medicine, Division of Medical Oncology, Kansas University Cancer Center, Kansas City, KS, U.S.A. ^[1] Department of Medicine, Division of Hematology/Oncology, South Florida University/Moffit Cancer Center, Tampa, FL, U.S.A. ^[2] Department of Medicine, Kansas University School of Medicine, Wichita, KS, U.S.A. ^[3] Department of Medicine, Division of Hematology/Oncology, University of Missouri-Kansas City, Kansas City, MO, U.S.A. ^[4] MetroWest Medical Center/Tufts University School of Medicine, Framingham, MA, U.S.A. ^[5] Department of Medicine, Division of Gastroenterology and Hepatology, University of Kansas Medical Center and Kansas Cancer Institute, Kansas City, KS, U.S.A. ^[6] Department of Medicine, Division of Medical Oncology, Kansas University Cancer Center, Kansas City, KS, U.S.A. asaeed@kumc.edu. ^[7]

关键词 Esophageal cancer carboplatin/paclitaxel geriatric oncology platinum/5-fluouracil trimodality therapy